Episode 066: Breast Cancer Series, Pt. 11-Metastatic HER2+ Breast Cancer
The Fellow on Call: The Heme/Onc Podcast
00:00
Third/Fourth-Line Options and Practical Sequencing
Discussion of tucatinib plus trastuzumab and capecitabine (HER2CLIMB) for CNS-active third-line therapy, and later-line choices including neratinib, margituximab, trastuzumab+chemo, and clinical trials.
Play episode from 21:44
Transcript
